CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway

Table 1 Correlation between CENPA mRNA expression and clinicopathological parameters of ccRCC patients

Parameter	Number	CENPA mRNA expression		P-value
		Low (n = 261)	High (n = 261)
Age (years)
< 60	235	120	115	0.725
≥ 60	287	141	146	0.725
Sex
Female	183	108	75	0.0033
Male	339	153	186	0.0033
T stage
T1 or T2	336	197	139	< 0.0001
T3 or T4	186	64	122	< 0.0001
N Stage
N0 or Nx	507	258	249	0.0326
N1	15	3	12	0.0326
M Stage
M0 or Mx	445	242	203	< 0.0001
M1	77	19	58	< 0.0001
G grade
G1 or G2 or Gx	245	157	88	< 0.0001
G3 or G4	277	104	173	< 0.0001
TNM stage
I + II	318	190	128	< 0.0001
III + IV	204	71	133	< 0.0001

The four-grid tables were made according to clinicopathological characteristics and the CENPA expression level. Statistical analyses were conducted via Pearson's χ2 test. P < 0.05 was considered statistically significant

ISSN: 1479-5876